Sirolimus, tacrolimus and low-dose methotrexate based GVHD prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allo-HCT

Encouraging results have been reported with sirolimus, tacrolimus, and low-dose methotrexate after non-myeloablative allogeneic hematopoietic cell transplantation. We conducted a retrospective analysis of 71 patients with lymphoid malignancies treated with this prophylaxis regimen after non-myeloabl...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Leuk Lymphoma
Autori principali: Ceberio, Izaskun, Devlin, Sean M., Sauter, Craig, Barker, Juliet N., Castro-Malaspina, Hugo, Giralt, Sergio, Ponce, Doris M., Lechner, Lauren, Maloy, Molly A., Goldberg, Jenna D., Perales, Miguel-Angel
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4379042/
https://ncbi.nlm.nih.gov/pubmed/24913499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2014.930851
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi